Squarepoint’s Rockwell Medical RMTI Stock Holding History

Squarepoint’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,670	Closed	-$54.5K	–	5274
2024 Q4	$54.5K	Buy	+2,670	New	+$77.9K	﹤0.01%	4832

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Squarepoint's RMTI Position: Q3 2025 in Review

Squarepoint sold out of Rockwell Medical (RMTI) in Q3 2025, closing a stake of 5,317 shares — an estimated $45.1K sold.

Squarepoint first reported a position in RMTI in Q4 2017 and held it in 10 quarters. The position peaked at $290K in Q3 2020. 36 funds tracked by Wall St. Rank hold RMTI as of Q3 2025.

Squarepoint reported no remaining Rockwell Medical position as of Q3 2025 after selling out during the quarter.
Squarepoint sold 5,317 Rockwell Medical shares in Q3 2025, an estimated $45.1K.
Squarepoint first reported a position in Rockwell Medical in Q4 2017 and held it in 10 quarters.
Squarepoint's Rockwell Medical position peaked at $290K in Q3 2020.
36 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.